Treatment of Older Women With Endometrial Cancer: Improving Outcomes With Personalized Care

2016 ◽  
Vol 36 ◽  
pp. 164-174 ◽  
Author(s):  
Linda Duska ◽  
Armin Shahrokni ◽  
Melanie Powell
Author(s):  
Linda Duska ◽  
Armin Shahrokni ◽  
Melanie Powell

Endometrial cancer is the most common gynecologic cancer, and with a median age of 62 at diagnosis, it affects a significant number of older women. With increasing age and obesity rates in the world’s population, there is an anticipated concomitant increase in older women with endometrial cancer. Older women are more likely to die of endometrial cancer compared with younger patients. Reasons for this include more aggressive tumor biology, less favorable clinicopathologic features, and more advanced disease. Other factors, however, such as reluctance to offer surgical treatment to the older patient and increased complications of treatment are likely to be important. Management of endometrial cancer requires multidisciplinary care (surgery, radiation therapy, and systemic therapy). For each treatment, the feasibility (related to technical aspect of the procedure/treatment), side effects and safety (related to older-patient factors), and the overall benefit as it pertains to older women with endometrial cancer should be assessed carefully with a multidisciplinary approach. Despite the importance of these issues, the data are limited to answer these issues with clarity. In this article, we will review each treatment modality for older women with endometrial cancer. We will introduce the components of comprehensive geriatric assessment and their practical implication for older women with cancer in general and older women with endometrial cancer specifically.


1995 ◽  
Vol 50 (11) ◽  
pp. 779-780
Author(s):  
Sarah Feldman ◽  
Francis E. Cook ◽  
Bernard L. Harlow ◽  
Ross S. Berkowitz

2019 ◽  
Author(s):  
I Berlev ◽  
Y Trifanov ◽  
Z Ibragimov ◽  
O Smirnova ◽  
K Guseinov ◽  
...  

1995 ◽  
Vol 56 (3) ◽  
pp. 376-381 ◽  
Author(s):  
Sarah Feldman ◽  
E.Francis Cook ◽  
Bernard L. Harlow ◽  
Ross S. Berkowitz

2017 ◽  
Vol 6 (2) ◽  
pp. 33-53
Author(s):  
Kwok-Leung Cheung ◽  
David Morgan ◽  
Etienne Brain ◽  
Philip Poortmans ◽  
Ruth Parks ◽  
...  

Author(s):  
Gabriele Siesto ◽  
Stefano Uccella ◽  
Fabio Ghezzi ◽  
Antonella Cromi ◽  
Francesca Zefiro ◽  
...  

2014 ◽  
Vol 24 (6) ◽  
pp. 1015-1020 ◽  
Author(s):  
Hei-Yu Lau ◽  
Yi-Jen Chen ◽  
Ming-Shyen Yen ◽  
Kuan-Chong Chao ◽  
Ru-Fen Chen ◽  
...  

ObjectiveThe aim of this study is to compare the clinicopathological features and survival of young women with endometrial cancer (aged <50 years) with those of older women with endometrial cancer (aged ≥50 years).MethodsWe conducted a retrospective cohort study of patients with histologically confirmed endometrial cancer treated at the Taipei Veterans General Hospital from 2001 to 2010.ResultsOne hundred forty-six patients (28.5%) were aged younger than 50 years at diagnosis. The median follow-up was 36.5 months (range, 0.9–121.7 months). Low body mass index (P< 0.001), nulliparity (P< 0.001), less medical illness (P< 0.001), synchronous primary ovarian cancer (P= 0.001), endometrioid type (P= 0.005), low tumor grade (P< 0.001), no para-aortic lymph node involvement (P< 0.047), less myometrial invasion (P< 0.001), and no vascular space invasion (P= 0.001) were common among the younger women compared with the older women. There were significant differences in the disease-free survival (P= 0.006) and overall survival (P= 0.004) between the 2 groups. In the multivariate Cox model, advanced stage had an effect on both disease-free survival (P= 0.004) and overall survival (P= 0.050).ConclusionsNulliparity, body mass index less than or equal to 23 kg/m2, endometrioid type, low-grade tumor, synchronous primary ovarian cancer, and favorable survival were common among the younger women.


Author(s):  
Kathleen Moore ◽  
Molly A. Brewer

The incidence of endometrial cancer is increasing, and the age of onset is younger than in prior years. Although endometrial cancer still occurs more commonly in older women, for whom the mortality rate is increasing, it also is being diagnosed in younger and younger women. The underlying cause of the increase in incidence is the epidemic of obesity and the resulting hyperinsulinemia. Conservative treatment may be indicated for younger women who wish to retain their fertility. Lifestyle modifications such as diet and exercise can modulate the risk of developing endometrial cancer as well as prevent recurrence and other comorbidities associated with obesity.


Sign in / Sign up

Export Citation Format

Share Document